BioCryst Pharmaceuticals
BCRX
#4607
Rank
โ‚ฌ1.52 B
Marketcap
7,35ย โ‚ฌ
Share price
2.39%
Change (1 day)
2.71%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚ฌ0.74 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is โ‚ฌ0.74 B. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚ฌ0.74 B7.99%
2022-12-31โ‚ฌ0.69 B32.56%
2021-12-31โ‚ฌ0.52 B128.05%
2020-12-31โ‚ฌ0.22 B203.28%
2019-12-31โ‚ฌ75.39 M39.7%
2018-12-31โ‚ฌ53.96 M18.33%
2017-12-31โ‚ฌ45.6 M-10.71%
2016-12-31โ‚ฌ51.07 M84.76%
2015-12-31โ‚ฌ27.64 M12.17%
2014-12-31โ‚ฌ24.64 M13.49%
2013-12-31โ‚ฌ21.71 M-4.33%
2012-12-31โ‚ฌ22.69 M-1.74%
2011-12-31โ‚ฌ23.1 M
2000-12-31โ‚ฌ0.01 M
1997-12-31โ‚ฌ0.08 M-66.67%
1996-12-31โ‚ฌ0.25 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚ฌ0.67 B-9.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.23 B 66.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.35 M-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.21 B-71.61%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ21.07 B 2,741.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ2.15 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.34 B 2,508.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ0.77 B 4.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ10.94 M-98.52%๐Ÿ‡บ๐Ÿ‡ธ USA